Duality Biotherapeutics (HKG:9606) made a stellar trading debut in Hong Kong on Tuesday morning as its shares soared over 91% at the opening bell, defying the stock market volatility caused by the tariff war between the world's two largest economies.
The Chinese biotech firm opened at HK$181 per share, well above its initial public offering price of HK$94.60. As of 10:41 a.m., Hong Kong time, the stock traded at HK$209.60.
The company's debut takes place against a backdrop of heightened uncertainty in global equity markets, driven by escalating US-China trade tensions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.